Evaluation of OxPL Levels in Patients Undergoing Coronary Angiography: A Cross-Sectional Study
Archives of Medical Laboratory Sciences,
Vol. 7 (2021),
13 March 2021
,
Page 1-6 (e12)
https://doi.org/10.22037/amls.v7.34602
Abstract
Background and Aim: Coronary ectasia is one of the prevalent cardiovascular diseases worldwide. It causes many deaths annually ranged between 9% to 10% which is dependent on related risk factors. The main pathogenesis has not been determined yet; however, it has been shown, that increased lipid profiles and their oxidation in patients can cause endothelial cell dysfunction and thrombosis. Therefore, here we investigated the oxidized phospholipids (OxPLs) role in the pathogenesis of coronary artery disease.
Methods: This cross-sectional study was performed in Shariati Hospital, Tehran. Accordingly, patients with coronary artery angiography indications (n=360) were included and classified into one of the following three groups, based on the angiographic results: 1) normal coronary artery (not dysfunction in vessels) or mild CAD (only intimal irregularity or less than 3% narrowing without ectasia); 2) vessel dilation more than 1.5 times compared to the normal part of the vessel or compared to the normal size according to age and gender in one or more coronary vessels; and 3) patients with more than 50% stenosis in one of the coronary arteries. The peripheral blood was collected from patients in EDTA anticoagulants container tubes and the OxPL level was measured using an ELISA kit.
Results: The results showed that the amount of OxPL in the third and second groups was higher than in the first group. It was also found that hyperlipidemia, diabetes, hypertension, and smoking were higher in the third and second groups; all mentioned findings were statistically significant (p-value <0.05).
Conclusion: According to the findings of this study, it was shown that an increase in OxPL in patients with coronary ectasia can be considered as a risk factor for disease progression; OxPL measurement can be used to identify high-risk individuals.
*Corresponding Author: Seyed Abdolhussein Tabatabaei; Email: tabatabaeiseyedah@gmailcom; ORCID iD: 0000-0001-5091-6066
Please cite this article as: Nikdoust F, Lashkari Zadeh F, Tabatabaei SA. Evaluation of OxPL Levels in Patients Undergoing Coronary Angiography: A Cross-Sectional Study. Arch Med Lab Sci. 2021;7:1-6 (e12). https://doi.org/10.22037/amls.v7.34602
- Coronary Ectasia
- Risk Factor
- Oxidative Phospholipid
- Angiography
How to Cite
References
Mariappan S, Sivakumar G, Saravanan R, Satheeshkumar S, Veeramani S, Balasubramanian S, et al. Analysis of Traditional Risk Factors of Atherosclerosis and Novel Risk Markers of Inflammation in Coronary Ectasia Can We Solve The Enigma?? 2020; DOI: 10.21203/rs.3.rs-71388/v1
Boles U, Johansson A, Wiklund U, Sharif Z, David S, McGrory S, et al. Cytokine disturbances in coronary artery ectasia do not support atherosclerosis pathogenesis. International journal of molecular sciences. 2018;19(1):260.
Pouladzadeh M, Safdarian M, Eshghi P, Abolghasemi H, Sheibani B, Choghakabodi PM, et al. A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on COVID-19-related cytokine storm. Internal and emergency medicine. 2021:1-11.
Boles U, Eriksson P, Zhao Y, Henein MY. Coronary artery ectasia: remains a clinical dilemma. Coronary artery disease. 2010;21(5):318-20.
Saba B, Eslamnik P, Heidarzadeh H, Vahdatnejad J. Depression in patients with multiple sclerosis. International Journal of Pharmaceutical Research. 2019;11(1):1089-94.
Devabhaktuni S, Mercedes A, Diep J, Ahsan C. Coronary artery ectasia-a review of current literature. Current cardiology reviews. 2016;12(4):318-23.
Zadeh FJ, Akbari T, Samimi A, Davari N, Rezaeeyan H. The role of molecular mechanism of Ten-Eleven Translocation2 (TET2) family proteins in pathogenesis of cardiovascular diseases (CVDs). Molecular biology reports. 2020:1-7.
Yasar AS, Erbay AR, Ayaz S, Turhan H, Metin F, Ilkay E, et al. Increased platelet activity in patients with isolated coronary artery ectasia. Coronary artery disease. 2007;18(6):451-4.
Haybar H, Shahrabi S, Rezaeeyan H, Shirzad R, Saki N. Endothelial cells: from dysfunction mechanism to pharmacological effect in cardiovascular disease. Cardiovascular Toxicology. 2019;19(1):13-22.
Byun YS, Lee J-H, Arsenault BJ, Yang X, Bao W, DeMicco D, et al. Relationship of oxidized phospholipids on apolipoprotein B-100 to cardiovascular outcomes in patients treated with intensive versus moderate atorvastatin therapy: the TNT trial. Journal of the American College of Cardiology. 2015;65(13):1286-95.
Ravandi A, Leibundgut G, Hung M-Y, Patel M, Hutchins PM, Murphy RC, et al. Release and capture of bioactive oxidized phospholipids and oxidized cholesteryl esters during percutaneous coronary and peripheral arterial interventions in humans. Journal of the American College of Cardiology. 2014;63(19):1961-71.
Pouladzadeh M, Safdarian M, Choghakabodi PM, Amini F, Sokooti A. Validation of red cell distribution width as a COVID-19 severity screening tool. Future Sci OA. 2021 Aug; 7(7): FSO712.
Zadeh FJ, Mohammadtaghizadeh M, Bahadori H, Saki N, Rezaeeyan H. The role of exogenous Fibrinogen in cardiac surgery: stop bleeding or induce cardiovascular disease. Molecular biology reports. 2020:1-10.
Antoniadis AP, Chatzizisis YS, Giannoglou GD. Pathogenetic mechanisms of coronary ectasia. International journal of cardiology. 2008;130(3):335-43.
Aboeata AS, Sontineni SP, Alla VM, Esterbrooks DJ. Coronary artery ectasia: current concepts and interventions. Front Biosci (Elite Ed). 2012;4(2):300-10.
Haybar H, Rezaeeyan H, Shahjahani M, Shirzad R, Saki N. T‐bet transcription factor in cardiovascular disease: Attenuation or inflammation factor? Journal of cellular physiology. 2019;234(6):7915-22.
Vittos O, Toana B, Vittos A, Moldoveanu E. Lipoprotein-associated phospholipase A2 (Lp-PLA2): a review of its role and significance as a cardiovascular biomarker. Biomarkers. 2012;17(4):289-302.
Kızıltunç E, Gök M, Kundi H, Çetin M, Topçuoğlu C, Gülkan B, et al. Plasma thiols and thiol-disulfide homeostasis in patients with isolated coronary artery ectasia. Atherosclerosis. 2016;253:209-13.
Pankow JS, Tang W, Pankratz N, Guan W, Weng L-C, Cushman M, et al. Identification of genetic variants linking protein C and lipoprotein metabolism: the ARIC study (Atherosclerosis Risk in Communities). Arteriosclerosis, thrombosis, and vascular biology. 2017;37(3):589-97.
Tsimikas S, Kiechl S, Willeit J, Mayr M, Miller ER, Kronenberg F, et al. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study. Journal of the American College of Cardiology. 2006;47(11):2219-28.
Zadeh FJ, Ghasemi Y, Bagheri S, Maleknia M, Davari N, Rezaeeyan H. Do exosomes play role in cardiovascular disease development in hematological malignancy? Molecular biology reports. 2020:1-7.
Tsimikas S, Duff GW, Berger PB, Rogus J, Huttner K, Clopton P, et al. Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein (a). Journal of the American College of Cardiology. 2014;63(17):1724-34.
Kiechl S, Willeit J, Mayr M, Viehweider B, Oberhollenzer M, Kronenberg F, et al. Oxidized phospholipids, lipoprotein (a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study. Arteriosclerosis, thrombosis, and vascular biology. 2007;27(8):1788-95.
- Abstract Viewed: 250 times
- PDF Downloaded: 158 times